These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3670467

  • 1. Metamizole: a 100-year-old grief.
    Levy M, Shapiro S.
    Ned Tijdschr Geneeskd; 1987 Sep 19; 131(38):1680-3. PubMed ID: 3670467
    [No Abstract] [Full Text] [Related]

  • 2. [The use of metamizole as a risk factor in the occurrence of agranulocytosis].
    Vlakhov V, Bakracheva N, Popova L.
    Vutr Boles; 1988 Sep 19; 27(2):80-5. PubMed ID: 3046147
    [Abstract] [Full Text] [Related]

  • 3. [Metamizole: 100 years of grief].
    Offerhaus L.
    Ned Tijdschr Geneeskd; 1987 Mar 21; 131(12):479-81. PubMed ID: 3574499
    [No Abstract] [Full Text] [Related]

  • 4. [Metamizole: a 100-year-old misery].
    Ned Tijdschr Geneeskd; 1987 May 16; 131(20):875-6. PubMed ID: 3587424
    [No Abstract] [Full Text] [Related]

  • 5. [Agranulocytosis and metamizole].
    Ugeskr Laeger; 1982 Mar 15; 144(11):813. PubMed ID: 7101514
    [No Abstract] [Full Text] [Related]

  • 6. [2 cases of allergic agranulocytosis caused by metamizole (sodic noramidopyrine methanesulfonate)].
    Puxeddu A, Ferrara G, Scionti L.
    Clin Ter; 1979 Jul 15; 90(1):83-8. PubMed ID: 535331
    [No Abstract] [Full Text] [Related]

  • 7. [Metamizole: an unbearable risk?].
    Forth W.
    MMW Munch Med Wochenschr; 1981 Jul 10; 123(28):1135-7. PubMed ID: 6790946
    [No Abstract] [Full Text] [Related]

  • 8. [Benefit-risk considerations in metamizole treatment. Rational recommendations for indications and contra-indications according to current knowledge].
    Ell C, Domschke S, Domschke W.
    Fortschr Med; 1982 Apr 15; 100(14):615-8. PubMed ID: 7084847
    [No Abstract] [Full Text] [Related]

  • 9. [Agranulocytosis and metamizole].
    Hoerder U, König HJ, Hartwich G.
    Dtsch Med Wochenschr; 1982 Dec 17; 107(50):1923-6. PubMed ID: 7140576
    [Abstract] [Full Text] [Related]

  • 10. [Agranulocytosis caused by dipyrone. Apropos of a case].
    Pueyo Fresneda JA, de la Torre Calatayud A.
    Rev Esp Anestesiol Reanim; 1986 Dec 17; 33(1):51. PubMed ID: 3704244
    [No Abstract] [Full Text] [Related]

  • 11. Agranulocytosis and dipyrone.
    Vlahov V, Bacracheva N.
    Lancet; 1989 Nov 18; 2(8673):1215. PubMed ID: 2572920
    [No Abstract] [Full Text] [Related]

  • 12. Marrow toxicity of dipyrone.
    Mehta BC.
    J Assoc Physicians India; 1984 Jul 18; 32(7):614. PubMed ID: 6501207
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Agranulocytosis caused by dipyrone. Case reports].
    Castiglioni F, Broggini M, Baratelli E, Battaglia A, Besozzi M, Gorini L.
    Clin Ter; 1984 Jul 18; 130(3-4):179-83. PubMed ID: 2529092
    [Abstract] [Full Text] [Related]

  • 16. The incidence of dipyrone-induced agranulocytosis in Greece during 1975.
    Varonos DD, Santamouris S, Karambali S.
    J Int Med Res; 1979 Jul 18; 7(6):564-8. PubMed ID: 520659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The danger of novalgin.
    Sedaghat A.
    Pahlavi Med J; 1977 Apr 18; 8(2):275-6. PubMed ID: 887287
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.